Pisters Selected as Next MD Anderson Cancer Center President
Peter W. T. Pisters, MD, MHCM, has been chosen as the next president of The University of Texas MD Anderson Cancer Center. Pisters has served as president and CEO of University of Health Network (UHN) of Toronto since 2015.
Peter W. T. Pisters, MD, MHCM
Peter W. T. Pisters, MD, MHCM
Peter W. T. Pisters, MD, MHCM, has been chosen as the next president of The University of Texas MD Anderson Cancer Center. Pisters has served as president and CEO of University of Health Network (UHN) of Toronto since 2015.
Pisters was unanimously selected for the position by the UT System Board of Regents at a special meeting on August 25. He will be the fifth president of the Houston-based cancer center.
Prior to joining UHN, Pisters served as a cancer surgeon, researcher, professor, and administrator. He spent 20 years working at MD Anderson, including serving as the medical director of MD Anderson’s 6 regional cancer centers, as a clinical consultant for the center for global oncology (now known as MD Anderson Cancer Network), and section chief for sarcoma surgery, with a specialty focus in the management of sarcoma and gastrointestinal cancer patients.
During his time with MD Anderson, Pisters was honored with several awards, including 2 Fellows Outstanding Teacher Awards and 2 Faculty Excellence Awards.
“MD Anderson is focused every day on one singular goal,” said UT System Chancellor William H. McRaven. “Identifying the right leader for this celebrated national treasureone that inspires hope in people around the world—is a monumental decision, and I believe we have found that leader in Dr Pisters. As a known and admired former faculty member and administrator, Dr Pisters can transition smoothly and help MD Anderson move forward very effectively.”
Pisters is a graduate of the University of Western Ontario’s Schulich School of Medicine and Dentistry. He completed his internship and residency at New York University School of Medicine Center Bellevue Hospital and also holds a master’s degree in health care management from Harvard University.
Past MD Anderson president Ron DePinho, MD, announced earlier this year he would be stepping down from his position. Marshall Hicks, MD, stepped in as interim president and will continue serving in that role until Pisters begins his new role later this year.
KEYNOTE-859 Outcomes Influence NCCN Guidelines on Pembrolizumab in Upper GI Cancer
April 10th 2024During a Case-Based Roundtable® event, David Zhen, MD, discussed how treatment of upper gastrointestinal cancer with pembrolizumab and chemotherapy is impacted by PD-L1 composite positive score, in the second article of a 2-part series.
Read More
The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
February 15th 2021In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Listen
